Rahlfs Capital’s Amgen AMGN Stock Holding History

Rahlfs Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$304K	Hold	840	–	–	0.22%	74
2026 Q1	$296K	Hold	840	–	–	0.22%	74
2025 Q4	$275K	Hold	840	–	–	0.21%	74
2025 Q3	$237K	Hold	840	–	–	0.19%	81
2025 Q2	$235K	Hold	840	–	–	0.21%	80
2025 Q1	$262K	Hold	840	–	–	0.26%	70
2024 Q4	$219K	Buy	+840	New	+$249K	0.22%	74

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Rahlfs Capital's AMGN Position: Q2 2026 in Review

Rahlfs Capital held its Amgen (AMGN) position steady in Q2 2026 at 840 shares worth $304K. The position accounts for 0.22% of the portfolio, ranked #74.

Rahlfs Capital first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Rahlfs Capital held 840 shares of Amgen worth $304K as of Q2 2026.
Rahlfs Capital left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.22% of Rahlfs Capital's portfolio in Q2 2026, its #74 holding.
Rahlfs Capital first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Rahlfs Capital's 13F filing for Q2 2026, filed 28 Jul 2026.